American Journal of Physiology-Gastrointestinal and Liver Physiology · 2014 · 40 citations · 39 references
Life SciencesCell BiologyPathobiologyAutophagyCell SignalingCellular MetabolismAutophagy DysfunctionAutophagy DysregulationAutophagy ModulationAutophagy RegulationHepatic NecrosisHepatocellular NecrosisAutophagy ImpairmentAutophagy In Liver MetabolismAutophagy Under HypoxiaAutophagy-related Protein 7Hepatocellular Injury MechanismsHepatocellular Liver InjuryHigh-fat Diet-induced Liver InjuryOrgan Ischemia-reperfusion Injury
Ischemia-reperfusion injury (IRI) is a common clinical consequence of hepatic surgery, cardiogenic shock, and liver transplantation. A steatotic liver is particularly vulnerable to IRI, responding with extensive hepatocellular injury. Autophagy, a lysosomal pathway balancing cell survival and cell death, is engaged in IRI, although its role in IRI of a steatotic liver is unclear. The role of autophagy was investigated in high-fat diet (HFD)-fed mice exposed to IRI in vivo and in steatotic hepatocytes exposed to hypoxic IRI (HIRI) in vitro. Two inhibitors of autophagy, 3-methyladenine and bafilomycin A1, protected the steatotic hepatocytes from HIRI. Exendin 4 (Ex4), a glucagon-like peptide 1 analog, also led to suppression of autophagy, as evidenced by decreased autophagy-associated proteins [microtubule-associated protein 1A/1B-light chain 3 (LC3) II, p62, high-mobility group protein B1, beclin-1, and autophagy-related protein 7], reduced hepatocellular damage, and improved mitochondrial structure and function in HFD-fed mice exposed to IRI. Decreased autophagy was further demonstrated by reversal of a punctate pattern of LC3 and decreased autophagic flux after IRI in HFD-fed mice. Under the same conditions, the effects of Ex4 were reversed by the competitive antagonist exendin 9-39. The present study suggests that, in IRI of hepatic steatosis, treatment of hepatocytes with Ex4 mitigates autophagy, ameliorates hepatocellular injury, and preserves mitochondrial integrity. These data suggest that therapies targeting autophagy, by Ex4 treatment in particular, may ameliorate the effects of IRI in highly prevalent steatotic liver.
39
Autophagy in the Pathogenesis of Disease
Beth Levine, Guido Kroemer · Cell · 2008 · 7K citations · Full text
Autophagy fights disease through cellular self-digestion
Noboru Mizushima, Beth Levine, Ana María Cuervo et al. · Nature · 2008 · 6.4K citations · Full text
Autophagy regulates lipid metabolism
Rajat Singh, Susmita Kaushik, Yongjun Wang et al. · Nature · 2009 · 3.9K citations · Full text
Elizabeth Axe, Simon Walker, Maria Manifava et al. · The Journal of Cell Biology · 2008 · 1.8K citations · Full text
Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion
Yutaka Matsui, Hiromitsu Takagi, Xueping Qu et al. · Circulation Research · 2007 · 1.5K citations